Sale!

MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the MSH2 gene, which are strongly linked to an increased risk of developing hereditary nonpolyposis colorectal cancer (HNPCC) type 1, also known as Lynch syndrome. This condition is characterized by a higher likelihood of developing colorectal cancer at a younger age than the general population, as well as an increased risk for other types of cancer. The test involves analyzing the patient’s DNA to detect any abnormalities or mutations in the MSH2 gene that could indicate the presence of or predisposition to this hereditary cancer syndrome.

Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test provides critical information for individuals with a family history of colorectal cancer or other related cancers. By identifying specific genetic mutations, the test enables healthcare providers to recommend appropriate surveillance, preventive measures, or treatment options to manage the risk of cancer. This proactive approach can significantly improve the quality of life and survival rates for individuals with a predisposition to HNPCC.

The cost of the MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families is immeasurable, offering a pathway to early intervention and personalized cancer risk management strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test

Are you concerned about your risk of developing colorectal cancer? The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test offered by DNA Labs UAE can provide valuable insights. Let’s explore the details of this test.

Test Components and Price

The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test is priced at AED 4400.0. The test requires either a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

You can expect to receive your test report within 3 to 4 weeks after the sample is submitted.

Method and Test Type

The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced testing method allows for the simultaneous analysis of multiple genes, including the MSH2 gene. The test specifically focuses on identifying mutations or variations in the MSH2 gene that may be associated with an increased risk of developing colorectal cancer or other cancers related to HNPCC (hereditary nonpolyposis colorectal cancer).

Doctor and Test Department

The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test is conducted under the supervision of an oncologist. The test is performed in the Genetics department of DNA Labs UAE.

Pre Test Information

Prior to undergoing the MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MSH2 Gene Colorectal Cancer, hereditary nonpolyposis type 1 NGS Genetic DNA Test gene MSH2.

Test Details

The MSH2 gene is associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. HNPCC is an inherited condition that increases the risk of developing colorectal cancer and other types of cancer, such as endometrial, ovarian, gastric, urinary tract, and small bowel cancer.

NGS genetic testing, which analyzes multiple genes simultaneously, including the MSH2 gene, can help identify mutations or variations in the MSH2 gene that may increase the risk of developing colorectal cancer or other HNPCC-related cancers.

By identifying individuals at higher risk, NGS genetic testing can guide medical management, including increased surveillance and screening for early detection and prevention of cancer.

It is crucial to note that NGS genetic testing should be performed by qualified healthcare professionals, such as genetic counselors or medical geneticists, who can interpret the results and provide appropriate recommendations based on the individual’s personal and family history.

Test Name MSH2 Gene Colorectal cancer hereditary nonpolyposis type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MSH2 Gene Colorectal cancer, hereditary nonpolyposis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSH2 Gene Colorectal cancer, hereditary nonpolyposis type 1 NGS Genetic DNA Test gene MSH2
Test Details

The MSH2 gene is one of several genes associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. HNPCC is an inherited condition that increases the risk of developing colorectal cancer and other types of cancer, including endometrial, ovarian, gastric, urinary tract, and small bowel cancer.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the MSH2 gene. This testing method can identify mutations or variations in the MSH2 gene that may be associated with an increased risk of developing colorectal cancer or other cancers related to HNPCC.

NGS genetic testing for the MSH2 gene and other genes associated with HNPCC can be helpful in identifying individuals who are at a higher risk of developing certain types of cancer. This information can be used to guide medical management, such as increased surveillance and screening for early detection and prevention of cancer.

It is important to note that NGS genetic testing should be performed by a qualified healthcare professional, such as a genetic counselor or medical geneticist, who can interpret the results and provide appropriate recommendations based on the individual’s personal and family history.